| 25 Aug, 09:53 pm | — | … | AstraZeneca Pharma India Limited has informed the Exchange about Action(s) taken or orders passed | nse |
| 25 Aug, 09:16 pm | — | … | AstraZeneca Pharma India Ltd - 506820 - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order | bse |
| 24 Aug, 08:55 pm | — | … | AstraZeneca Pharma India Limited has informed the Exchange about General Updates | nse |
| 24 Aug, 08:52 pm | — | … | AstraZeneca Pharma India Ltd - 506820 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Disclosure Of ESG Rating | bse |
| 11 Aug, 12:43 am | — | … | AstraZeneca Pharma India Ltd - 506820 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 11 Aug, 12:39 am | — | … | AstraZeneca Pharma India Limited has informed the Exchange regarding a press release dated August 10, 2026, titled "Press Release". | nse |
| 10 Aug, 01:56 pm | — | … | AstraZeneca Pharma India Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026. | nse |
| 10 Aug, 01:52 pm | — | … | AstraZeneca Pharma India Ltd - 506820 - Outcome Of The Board Meeting Held On Monday, August 10, 2026 | bse |
| 08 Aug, 11:38 am | — | … | AstraZeneca Pharma India Limited has informed the Exchange about General Updates | nse |
| 08 Aug, 11:34 am | — | … | AstraZeneca Pharma India Ltd - 506820 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015 | bse |
| 04 Aug, 10:35 am | — | … | AstraZeneca Pharma India Ltd - 506820 - Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company To Be Held On Monday, August 10, 2026 | bse |
| 30 Jul, 09:10 pm | — | … | AstraZeneca Pharma India Limited has informed the Exchange about Action(s) taken or orders passed | nse |
| 30 Jul, 09:08 pm | — | … | AstraZeneca Pharma India Ltd - 506820 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 | bse |
| 28 Jul, 07:20 pm | — | … | AstraZeneca Pharma India Limited has informed the Exchange about Action(s) initiated or orders passed | nse |
| 28 Jul, 07:15 pm | — | … | AstraZeneca Pharma India Ltd - 506820 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 | bse |
| 28 Jul, 01:22 pm | — | … | AstraZeneca Pharma India Limited has informed the Exchange about General Updates | nse |
| 28 Jul, 01:21 pm | — | … | AstraZeneca Pharma India Ltd - 506820 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015 | bse |
| 22 Jul, 03:48 pm | — | … | AstraZeneca Pharma India Limited has informed the Exchange regarding 'Communication to the shareholders w.r.t. TDS on Dividend'. | nse |
| 22 Jul, 09:06 am | — | … | AstraZeneca Pharma India Limited has informed the Exchange about Resignation of Director/KMP/SMP | nse |
| 21 Jul, 10:02 am | — | … | AstraZeneca Pharma India Limited has informed the Exchange about General Updates | nse |
| 21 Jul, 10:00 am | — | … | AstraZeneca Pharma India Ltd - 506820 - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) | bse |
| 18 Jul, 08:35 pm | — | … | AstraZeneca Pharma India Ltd - 506820 - Record Date For Payment Of Final Dividend | bse |
| 18 Jul, 08:19 pm | — | … | AstraZeneca Pharma India Limited has informed the Exchange that Record date for the purpose of Dividend is 31-Jul-2026. | nse |
| 18 Jul, 08:04 pm | — | … | AstraZeneca Pharma India Limited has informed the Exchange regarding 'Business Responsibility and Sustainability Report for the financial year ended March31, 2026'. | nse |
| 18 Jul, 07:00 pm | — | … | AstraZeneca Pharma India Ltd - 506820 - Reg. 34 (1) Annual Report. | bse |
| 16 Jul, 02:38 pm | — | … | AstraZeneca Pharma India Limited has informed the Exchange about General Updates | nse |
| 16 Jul, 02:25 pm | — | … | AstraZeneca Pharma India Ltd - 506820 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015 | bse |
| 06 Jul, 03:52 pm | — | … | AstraZeneca Pharma India Limited has informed the Exchange about General Updates | nse |
| 06 Jul, 03:48 pm | — | … | AstraZeneca Pharma India Ltd - 506820 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Appointment Of Senior Management Personnel (SMP) | bse |
| 16 Jun, 02:04 pm | — | … | AstraZeneca Pharma India Limited has informed the Exchange about General Updates | nse |
| 16 Jun, 02:01 pm | — | … | AstraZeneca Pharma India Ltd - 506820 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Appointment Of Senior Management Personnel | bse |
| 13 Jun, 12:21 pm | kmp_change | 3 | AstraZeneca Pharma India Limited informed the Exchange about the resignation of a Director/KMP/SMP (KMP change). | nse |
| 12 Jun, 12:29 pm | other | 1 | AstraZeneca Pharma India Limited informed the exchange about general updates, with no specific operational, financial, or transaction details disclosed. | nse |
| 11 Jun, 10:39 am | procedural | 0 | AstraZeneca Pharma India Limited informed the exchange about general updates. | nse |
| 09 Jun, 05:47 pm | procedural | 0 | AstraZeneca Pharmaceuticals AB submitted a copy of a SEBI Takeover Regulations (Reg 31(4)) disclosure to the exchange. | nse |
| 04 Jun, 03:42 pm | — | … | AstraZeneca Pharma India Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company | nse |
| 04 Jun, 03:39 pm | — | … | AstraZeneca Pharma India Ltd - 506820 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 | bse |
| 03 Jun, 09:07 pm | — | … | AstraZeneca Pharma India Limited has informed the Exchange about Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals | nse |
| 03 Jun, 09:03 pm | — | … | AstraZeneca Pharma India Ltd - 506820 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015 | bse |
| 01 Jun, 11:32 am | — | … | AstraZeneca Pharma India Ltd - 506820 - Information Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Resignation Of Senior Management Personnel | bse |
| 01 Jun, 11:30 am | — | … | AstraZeneca Pharma India Limited has informed the Exchange about General Updates | nse |
| 29 May, 08:08 pm | — | … | AstraZeneca Pharma India Ltd - 506820 - Compliances-Reg.24(A)-Annual Secretarial Compliance | bse |
| 26 May, 07:49 pm | — | … | AstraZeneca Pharma India Ltd - 506820 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 26 May, 07:47 pm | — | … | AstraZeneca Pharma India Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. | nse |
| 26 May, 07:43 pm | — | … | AstraZeneca Pharma India Limited has informed the Exchange regarding a press release dated May 26, 2026, titled "AstraZeneca Pharma India Limited marks consistent 33% growth as the Company announces its annual results for FY 2025-2026". | nse |
| 26 May, 07:16 pm | — | … | AstraZeneca Pharma India Ltd - 506820 - Outcome Of The Board Meeting Held On Tuesday, May 26, 2026 | bse |
| 21 May, 01:29 pm | — | … | AstraZeneca Pharma India Limited has informed the Exchange about General Updates | nse |
| 21 May, 01:26 pm | — | … | AstraZeneca Pharma India Ltd - 506820 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015 | bse |
| 20 May, 08:31 pm | — | … | AstraZeneca Pharma India Limited has informed the Exchange about General Updates | nse |
| 20 May, 08:27 pm | — | … | AstraZeneca Pharma India Ltd - 506820 - Determination Of Materiality - Details Of Key Managerial Personnel | bse |